Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. I.M. van Oort

Publicaties

[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study.

Arbeidsinzet bij percutane nefrolitholapaxie met versus zonder intra-operatieve cone-beam-CT: 18-maanden follow-up

Comparison of staff workload between percutaneous nephrolithotomy with and without intraoperative cone-beam CT: an 18-month postoperative analysis

Cost Comparison of Percutaneous Nephrolithotomy With and Without Intraoperative Cone-beam Computed Tomography: 18-month Postoperative Analysis

Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer

Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway

Exploratory Treatment-Selection Model of Intraoperative Cone-Beam Computed Tomography During Percutaneous Nephrolithotomy: Insights from RCT Data

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy

Pers/media

Trots op mooie dingen die het UMC Groningen doet op urologisch gebied

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 5 – GendergelijkheidSDG 10 – Minder ongelijkheid

Meer informatie over de Sustainable Development Goals.